Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases

Autor: Lin, Jessica J., Jiang, Ginger Y., Joshipura, Nencyben, Ackil, Jennifer, Digumarthy, Subba R., Rincon, Sandra P., Yeap, Beow Y., Gainor, Justin F., Shaw, Alice T.
Zdroj: In Journal of Thoracic Oncology April 2019 14(4):683-690
Databáze: ScienceDirect